Skip to content

Advanced Instruments (Belgium): what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

Advanced Instruments (Belgium)

BE 0789.792.311
NACE 46.460, Wholesale of pharmaceutical and medical goods
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€26,386
2024 · €36,032-€9,646
Equity
€14,961
2024 · -€11,425+€26,386
Cash
€167,308
2024 · €285,593-€118,285
Balance sheet total
€408,689
2024 · €616,634-€207,945

Largest movements

2024 to 2025
Assets
  • Receivables within one year -€154,474

    down €154,474 (-46.7%), from €331,041 to €176,568

    of which Trade receivables: -€151,595

  • Cash -€118,285

    down €118,285 (-41.4%), from €285,593 to €167,308

    mainly Trade debts (-€349,536) and Stocks and contracts (-€64,814)

  • Stocks and contracts +€64,814

    up €64,814, from €0 to €64,814

Equity and liabilities
  • Trade debts -€349,536

    down €349,536 (-70.6%), from €495,171 to €145,635

  • Accrued charges and deferred income +€85,040

    up €85,040 (+766%), from €11,098 to €96,137

  • Tax, wage and social debts +€27,277

    up €27,277 (+46.3%), from €58,931 to €86,207

    of which Taxes: +€18,436

  • Profit (loss) carried forward +€26,386

    up €26,386, from -€11,425 to €14,961

Income statement
  • Staff costs +€56,619

    up €56,619 (+204%), from €27,800 to €84,419

  • Gross operating margin +€49,478

    up €49,478 (+71.5%), from €69,218 to €118,697

  • Financial income +€19,447

    up €19,447 (+8,117%), from €240 to €19,687

  • Taxes +€12,413

    new in 2025: €12,413

  • Write-downs +€4,862

    new in 2025: €4,862

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €36,032
Gross operating margin +€49,478
Staff costs -€56,619
Write-downs -€4,862
Other operating charges -€37
Other operating items -€7,548
Financial income +€19,447
Financial charges +€2,909
Taxes -€12,413
Result 2025 €26,386
raises the resultlowers the resultnot broken down further in the accounts

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€118,285
Investment €0
Financing €0
Cash 2024 €285,593
Net result for the year +€26,386
Stocks and contracts -€64,814
Receivables within one year +€154,474
Trade debts -€349,536
Tax, wage and social debts +€27,277
Other debts +€2,889
Accrued charges and deferred income +€85,040
Cash 2025 €167,308
brings cash intakes cash out
Every line side by side 34 lines
Line Code 2024 2025 Change %
Total assets 20/58 €616,634 €408,689 -€207,945 -33.7%
Current assets 29/58 €616,634 €408,689 -€207,945 -33.7%
Stocks and contracts in progress 3 €0 €64,814 +€64,814
Stocks 30/36 €0 €64,814 +€64,814
Amounts receivable within one year 40/41 €331,041 €176,568 -€154,474 -46.7%
Trade receivables 40 €324,468 €172,873 -€151,595 -46.7%
Other amounts receivable 41 €6,573 €3,694 -€2,879 -43.8%
Cash at bank and in hand 54/58 €285,593 €167,308 -€118,285 -41.4%
Total equity and liabilities 10/49 €616,634 €408,689 -€207,945 -33.7%
Equity 10/15 -€11,425 €14,961 +€26,386
Profit (loss) carried forward 14 -€11,425 €14,961 +€26,386
Amounts payable 17/49 €628,059 €393,728 -€234,331 -37.3%
Amounts payable within one year 42/48 €616,962 €297,591 -€319,371 -51.8%
Trade debts 44 €495,171 €145,635 -€349,536 -70.6%
Suppliers 440/4 €495,171 €145,635 -€349,536 -70.6%
Taxes, remuneration and social security 45 €58,931 €86,207 +€27,277 +46.3%
Taxes 450/3 €58,931 €77,366 +€18,436 +31.3%
Remuneration and social security 454/9 €0 €8,841 +€8,841
Other amounts payable 47/48 €62,860 €65,749 +€2,889 +4.6%
Accrued charges and deferred income 492/3 €11,098 €96,137 +€85,040 +766%
Remuneration, social security and pensions 62 €27,800 €84,419 +€56,619 +204%
Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) 631/4 - €4,862 +€4,862
Other operating charges 640/8 €749 €786 +€37 +5.0%
Non-recurring operating charges 66A - €7,548 +€7,548
Gross operating margin 9900 €69,218 €118,697 +€49,478 +71.5%
Operating profit (loss) 9901 €40,669 €21,081 -€19,589 -48.2%
Financial income 75/76B €240 €19,687 +€19,447 +8,117%
Recurring financial income 75 €240 €19,687 +€19,447 +8,117%
Financial charges 65/66B €4,877 €1,968 -€2,909 -59.6%
Recurring financial charges 65 €4,877 €1,968 -€2,909 -59.6%
Profit (loss) for the period before taxes 9903 €36,032 €38,799 +€2,767 +7.7%
Income taxes 67/77 - €12,413 +€12,413
Profit (loss) for the period 9904 €36,032 €26,386 -€9,646 -26.8%
Profit (loss) for the period to be appropriated 9905 €36,032 €26,386 -€9,646 -26.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 24 October 2026 via checked.be.